Absolutely amazed there isnt more buying at these levels. The company has already tipped their hand on the skin product, including more applications for it than previously known. Projected revs from just that product alone of $18MM+ per year to start, putting them at the head of the cannabis bio class. Which, BTW,
means $1B+ market cap or $7+ on a .70 investment. Not bad, hard to believe there are better places for investor money.